News

COMPANY NEWS

09 Jul 2024 · 2 min read

FebriDx® now available to health care practitioners in Belgium

Lumos Diagnostics has extended its agreement with Henry Schein Europe, which will see the expansion of distribution of FebriDx® into Belgium...

Read article

COMPANY NEWS

04 Jul 2024 · 1 min read

Lumos Diagnostics Expands Distribution Partnership with Regional Health Care Group, Henry Schein’s Medical Business in Australia and New Zealand, for FebriDx®

FebriDx® - Lumos’ rapid point-of-care test – is now available to health care practitioners in Australia and New Zealand...

Read article

COMPANY NEWS

19 Jun 2024 · 1 min read

Lumos Receives US$400K Phase 1 Milestone Payment from Hologic

Lumos Diagnostics announced this week that it has received US$400,000 payment from Hologic...

Read article

COMPANY NEWS

16 May 2024 · 1 min read

New FebriDx® Study | Journal of Antimicrobial Chemotherapy

Antimicrobial resistance (AMR) is a growing threat to global health, driven largely by the overuse of antibiotics...

Read article

COMPANY NEWS

06 May 2024 · 1 min read

Lumos Signs Major Development and IP Agreements with Hologic

Lumos Diagnostics has announced that it has successfully completed the first phase of its Development Agreement...

Read article

COMPANY NEWS

30 Apr 2024 · 1 min read

Quarterly | Interview with LDX CEO, Doug Ward

In this video, Lumos Diagnostics CEO Doug Ward discusses the Company's recent quarterly activity statement and cash flow report...

Read article

COMPANY NEWS

29 Apr 2024 · 1 min read

Hologic enables maiden net free cash flow

A wrap-up of Lumos’ performance this Quarter was covered by Foster Stockbroking on ListCorp today...

Read article

COMPANY NEWS

11 Apr 2024 · 1 min read

Lumos to exhibit at 2024 Urgent Care Convention

Lumos is excited to be exhibiting at the 2024 Urgent Care Convention April 13-17...

Read article

COMPANY NEWS

08 Apr 2024 · 3 min read

New FebriDx® study published in peer-reviewed journal: Infectious Diseases and Clinical Microbiology

Lumos is pleased to announce that respected international journal, Infectious Diseases...

Read article

COMPANY NEWS

12 Feb 2024 · 1 min read

Lumos Appoints Henry Schein as US Distributor for FebriDx®

Lumos Diagnostics (ASX: LDX) has today announced it has signed an agreement...

Read article

COMPANY NEWS

13 Dec 2023 · 1 min read

CBS News | CDC warns overuse of antibiotics may cause antimicrobial-resistant infections

The Center for Disease Control has warned of the dangers of antibiotic overuse, which can make...

Read article

COMPANY NEWS

11 Sep 2023 · 2 min read

US FDA Grants Emergency Use Authorization For ViraDx™

Lumos Diagnostics (ASX: LDX) had today announced that the US Food...

Read article